THE DEAL, AT A GLANCE
From the announcementPrevencio
01Who is involvedBacked by VariousFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedPrevencio raised $30M Series BFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersPrevencio is positioned around an AI blood test that predicts coronary artery disease risk and 5-year MACE risk from a standard blood draw.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Prevencio · Financing Record
Explore source-linked visual explanations for Prevencio. Unsupported claims are withheld while source review continues.
Record 1525 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →